Core Scientific (CORZ) Preferred Stock Liabilities (2020 - 2021)

Core Scientific has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $44.5 million for Q4 2021.

• Preferred Stock Liabilities for Q4 2021 came in at $44.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2021 was $44.5 million (changed 0.0% YoY), and the FY2021 annual result was $44.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $44.5 million for Q4 2021 at Core Scientific, down from $345.0 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $345.0 million in Q3 2021 to a low of $44.5 million in Q4 2020.